Back to the top

Break Through Cancer, A New Research Consortium, Names First Class of Scientists Designated as Catalysts for Innovation and Collaboration

Break Through Cancer, A New Research Consortium, Names First Class of Scientists Designated as Catalysts for Innovation and Collaboration Highly skilled professional scientists at partner institutes will spur development of novel approaches to understanding cancer and developing new treatment strategies (CAMBRIDGE, MASS.) APRIL 25, 2023 – Break Through Cancer, a foundation designed to find new solutions to some of the most intractable challenges in cancer, has named four individuals as Break Through Cancer Scientists—Neelkanth Bardhan, Sreyashi Basu, Paola A. Guerrero, and Thomas R. Pisanic II. They are professional scientists who cooperate on and lead projects with the skills, knowledge, and......

Continue reading

Removing fallopian tubes can prevent ovarian cancers without causing menopause. But who’s eligible? | WBUR

JTNDaWZyYW1lJTIwd2lkdGglM0QlMjIxMDAlMjUlMjIlMjBoZWlnaHQlM0QlMjIxMjQlMjIlMjBzY3JvbGxpbmclM0QlMjJubyUyMiUyMGZyYW1lYm9yZGVyJTNEJTIybm8lMjIlMjBzcmMlM0QlMjJodHRwcyUzQSUyRiUyRnBsYXllci53YnVyLm9yZyUyRmhlcmVhbmRub3clMkYyMDIzJTJGMDMlMkYxNiUyRm92YXJpYW4tY2FuY2Vycy1mYWxsb3BpYW4tdHViZXMlMjIlM0UlM0MlMkZpZnJhbWUlM0U=Removing fallopian tubes can prevent ovarian cancers without causing menopause. But who's eligible? The American Cancer Society estimates that more than 19,000 women will be diagnosed with ovarian cancer this year. More than 13,000 of them will die from the disease, which is difficult to diagnose and to treat. That's why the Ovarian Cancer Research Alliance recommended earlier this year that women (particularly those done having children) consider adding surgery to remove their fallopian tubes to pelvic surgeries like hysterectomies or tubal ligations since most ovarian cancers start in the tubes. Among those performing the surgery is Dr. Michael Worley,......

Continue reading

More physicians are calling for fallopian tube removal to prevent ovarian cancer | STAT

More physicians are calling for fallopian tube removal to prevent ovarian cancer By Zeina Mohammed — Boston GlobeFeb. 23, 2023 Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women survive 5 years past their diagnosis, and 80 percent have no known risk factors. Now, a growing chorus of physicians is recommending a procedure that can significantly reduce the chances of developing ovarian cancer. The procedure is......

Continue reading

Calls grow for fallopian tube removal to prevent ovarian cancer – The Boston Globe

Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women survive 5 years past their diagnosis, and 80 percent have no known risk factors. Now, a growing chorus of physicians is recommending a procedure that can significantly reduce the chances of developing ovarian cancer. The procedure is called a salpingectomy — or removal of the fallopian tubes, where the majority of ovarian cancer cases begin. The operation,......

Continue reading

Fallopian tube removal advised for more women to prevent ovarian cancer | Washington Post

In some cases, those who are done with childbearing may be advised to have tubes removed if they are having another gynecological surgery anyway By Teddy Amenabar, Amy Goldstein and Lindsey Bever To prevent more cases of ovarian cancer, a major research and advocacy group is suggesting an aggressive prevention strategy: remove a woman’s fallopian tubes if she is undergoing pelvic surgery for another reason. The practice would apply to women, trans men or nonbinary people at average risk who don’t plan to have any or additional children. The fallopian tubes are hollow structures that allow eggs to travel from......

Continue reading

Break Through Barriers To Drive Progress: Cancer Moonshot Pathways | Forbes

Published on August 8, 2022 at Forbes.com Written by Russell Flannery   MIT Professor Tyler Jacks has made a mark in cancer work not only by his research but his ability to bring different organizations together. Through his leadership, Break Through Cancer has spurred a first-of-its-kind collaboration of five of the top cancer research centers in the world: Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MIT’s Koch Institute for Integrative Cancer Research, The University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. The effort, funded with $250 million of help from......

Continue reading

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers Funding is part of $50 million in grants to teams at five cancer centers charged to work together  Contact: Clayton Boldt, Ph.D. Office: 713-792-9518 Cell: 409-673-5582 crboldt@mdanderson.org  HOUSTON ― The University of Texas MD Anderson Cancer Center...

Continue reading

Break Through Cancer Announces $50M in Grants to Empower Researchers from Five Top Cancer Research Centers to Work as One

New cancer research foundation will help accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers using a bold new approach. CAMBRIDGE, Mass., April 19, 2022 – Today, one year after its founding, Break Through Cancer announced $50 million in grants to support several cutting-edge research projects using a novel “TeamLab” structure—designed to maximize interdisciplinary collaboration among...

Continue reading

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH | The Cancer Letter

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH April 9, 2021 President Joe Biden April 9 announced his FY2022 budgetary plans for ARPA-H—Advanced Research Projects Agency-Health—a federal entity designed to “deliver breakthroughs to find cures for cancer and other diseases.” In his initial White House budget proposal—dubbed skinny budget, or budget-lite—Biden is requesting $6.5 billion to fund ARPA-H. “The discretionary request calls for $6.5 billion to launch the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health (NIH),” a White House press release states. “With an initial focus......

Continue reading